Zobrazeno 1 - 10
of 245
pro vyhledávání: '"Faysal DANE"'
Autor:
Tuğba AKIN TELLİ, Nalan AKGÜL BABACAN, Özkan ALAN, Mehmet Akif ÖZTÜRK, Rahib HASANOV, Sinan KOCA, Süleyman HALİL, Eda TANRIKULU ŞİMŞEK, Tuğba BAŞOĞLU, Özlem ERCELEP, Faysal DANE, Perran Fulden YUMUK
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 10, Iss 1, Pp 74-79 (2022)
Aim:DR-70 is a newly developed immunoassay that detects fibrin degradation products in blood. We aimed to evaluate ability of DR-70 in monitoring treatment response in advanced gastrointestinal (GI) cancers.Materials and Methods:We prospectively enro
Externí odkaz:
https://doaj.org/article/0eecd9d0c2d943feb4b11316cac36178
Autor:
Tuğba Başoğlu, Kadriye Ebru Akar, Pelin Bağcı, Nalan Akgül Babacan, Mehmet Akif Öztürk, Fatih Emin Öztürk, Nazım Can Demircan, Rukiye Arıkan, Tuğba Akın Telli, Özlem Ercelep, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Balkan Medical Journal, Vol 39, Iss 1, Pp 12-20 (2022)
Background: Pancreatic ductal adenocarcinoma differs from other solid tumors with its unique immunosuppressive microenvironment and non-immunogenic feature. There are not many studies in the literature investigating the effect of these features on pr
Externí odkaz:
https://doaj.org/article/8851ad7ecb0946b8a21314805e33eb05
Autor:
Özkan ALAN, Özlem ERCELEP, Tuğba AKİN TELLİ, Eda TANRIKULU ŞİMŞEK, Rahib HASANOV, Tuğba BASOGLU, Mehmet Akif ÖZTÜRK, Serap KAYA, Nalan AKGUL BABACAN, Tunç LAÇİN, Emine BOZKURTLAR, Faysal DANE, Perran Fulden YUMUK
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 8, Iss 3, Pp 376-382 (2020)
Aim: Non-small cell lung cancer (NSCLC) accounts for 85% of all lung cancers. Although curative treatment is surgery in the early stages, disease relapse is common. In this study, we retrospectively evaluated the prognostic factors and outcomes of op
Externí odkaz:
https://doaj.org/article/3b461b5761e14dd396bd6eb9abbf448f
Autor:
Ozkan Alan, Tugba Akin Telli, Bilge Aktas, Sinan Koca, Ilker Nihat Ökten, Rahib Hasanov, Tugba Basoglu, Rukiye Arikan, Nazim Can Demircan, Ozlem Ercelep, Serap Kaya, Mustafa Umit Ugurlu, Handan Kaya, Nalan Akgul Babacan, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
World Journal of Surgical Oncology, Vol 18, Iss 1, Pp 1-9 (2020)
Abstract Purpose Neoadjuvant chemotherapy is the standard front-line treatment modality in locally advanced breast cancer. Achieving pathological complete response (pCR) is a significant prognostic factor for prolonged disease-free and overall surviv
Externí odkaz:
https://doaj.org/article/9854984b8d9e4981ac56e556ec7b4c9c
Autor:
Suayib Yalcin, Faysal Dane, Berna Oksuzoglu, Nuriye Yildirim Ozdemir, Abdurrahman Isikdogan, Metin Ozkan, Guzin Gonullu Demirag, Hasan Senol Coskun, Bulent Karabulut, Turkkan Evrensel, Mehmet Ali Ustaoglu, Feyyaz Ozdemir, Hande Turna, Tugba Yavuzsen, Faruk Aykan, Alper Sevinc, Hakan Akbulut, Deniz Yuce, Mutlu Hayran, Saadettin Kilickap
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Combination of gemcitabine and nab-paclitaxel has superior clinical efficacy than gemcitabine alone. Nevertheless, health-related quality of life. (QoL) associated with this combination therapy when administered at first-line in a
Externí odkaz:
https://doaj.org/article/1ae3c043ebb54a6c82250c0cb4ea7be9
Autor:
Faysal Dane, Kirhan Ozgurdal, Şuayib Yalçın, Mustafa Benekli, Nuri Faruk Aykan, İdris Yücel, Metin Özkan, Turkkan Evrensel, Alper Sevinç, Hasan Şenol Coskun, Ulus Ali Sanli, Ismail Oguz Kara, Perran Fulden Yumuk
Publikováno v:
BMJ Open, Vol 10, Iss 3 (2020)
ObjectivesRegorafenib improved overall survival in patients with metastatic colorectal cancer (mCRC) refractory to standard therapies in two randomised, phase III trials, but has not been evaluated in Turkey. REGARD evaluated the safety and efficacy
Externí odkaz:
https://doaj.org/article/b3153538a6d44e7c98c28e54c95923dd
Autor:
Ozkan Alan, Tugba Akin Telli, Ozlem Ercelep, Eda Tanrikulu Simsek, Tugba Basoglu Tuylu, Aydan Mutis, Rahib Hasanov, Serap Kaya, Nalan Akgül Babacan, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Journal of Medical Case Reports, Vol 12, Iss 1, Pp 1-5 (2018)
Abstract Background Chordoma is a rare malignant tumor of the skull base and axial skeleton, with an incidence of less than 0.1/100,000 per year. Patients with advanced chordoma have a poor prognosis due to locoregional recurrence with infiltration a
Externí odkaz:
https://doaj.org/article/bab79c9c4ed4436996ff2f10859b7947
Publikováno v:
Journal of Oncological Sciences, Vol 3, Iss 2, Pp 66-70 (2017)
Soft tissue sarcomas, which originate from the mesenchymal tissue, represent a rare disease group with more than 100 subtypes. Primary treatment is surgical excision. In locally-advanced or metastatic cases, systemic treatment is the only therapeutic
Externí odkaz:
https://doaj.org/article/8ffb292b0013471db217b2e24ed0a5e0
Autor:
Roman Ibrahimov, Beste M. Atasoy, Fuat Dede, Hakki Arikan, Zeynep Ozen, Zerrin Ozgen, Faysal Dane, Ufuk Abacioglu
Publikováno v:
Journal of Radiation Research and Applied Sciences, Vol 9, Iss 1, Pp 63-67 (2016)
Aim: To analyze the dosimetric factors affecting long-term renal function in patients with gastric cancer following postoperative radiotherapy with concomitant chemotherapy to the upper abdomen. Methods: Between January 2005 and July 2010, 13 patient
Externí odkaz:
https://doaj.org/article/499a66f811f64ecda22ef4a0a99a46b9
Autor:
Mustafa Deniz, Beste M. Atasoy, Faysal Dane, Güray Can, Can Erzik, Şule Çetinel, Berrak Ç. Yeğen
Publikováno v:
Journal of Radiation Research and Applied Sciences, Vol 8, Iss 2, Pp 234-242 (2015)
Purpose: The present study was conducted to characterize the possible therapeutic effects of glucagon-like peptide (GLP)-1 and GLP-2 against oxidative damage in the ileum and colon of irradiated rats. Methods and materials: Sprague-Dawley rats of bot
Externí odkaz:
https://doaj.org/article/90d12441875b4109a2f99ce8b3557574